Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-12 Sale |
2024-08-14 4:50 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
84,774 | $34.19 | $2,898,314 | 2,786,796 (Direct) |
View |
| 2024-08-06 Sale |
2024-08-08 5:39 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
112,994 | $31.54 | $3,563,807 | 2,871,570 (Direct) |
View |
| 2024-07-31 Sale |
2024-08-02 4:21 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
88,839 | $33.5 | $2,976,346 | 2,984,564 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-31 5:03 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
50,000 | $33.86 | $1,692,890 | 3,073,403 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-31 4:40 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
2,154 | $33.54 | $72,245 | 119,668 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-31 4:39 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
274 | $33.54 | $9,190 | 43,161 (Direct) |
View |
| 2024-07-24 Sale |
2024-07-26 7:49 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
135,000 | $33.78 | $4,560,363 | 3,123,403 (Direct) |
View |
| 2024-07-19 Sale |
2024-07-23 5:16 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
150,000 | $32.98 | $4,946,935 | 3,258,403 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 6:46 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
25,000 | $32.93 | $823,188 | 3,408,403 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-09 4:07 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
36,118 | $28.24 | $1,020,016 | 3,433,403 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-03 4:56 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
89,082 | $27.58 | $2,457,286 | 3,469,521 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 5:18 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,646 | $28.31 | $74,908 | 116,575 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 5:17 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
7,683 | $28.31 | $217,506 | 297,080 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 4:14 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
895 | $24.92 | $22,303 | 57,479 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 4:13 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
2,652 | $24.92 | $66,088 | 145,228 (Direct) |
View |
| 2024-06-03 Purchase |
2024-06-05 8:45 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
130,000 | $21.21 | $2,757,117 | 3,862,697 (Indirect Direct) |
View |
| 2024-06-03 Sale |
2024-06-04 4:20 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
262 | $20.55 | $5,384 | 37,747 (Direct) |
View |
| 2024-05-29 Purchase |
2024-05-31 5:37 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
40,000 | $21.07 | $842,604 | 3,732,697 (Indirect Direct) |
View |
| 2024-05-23 Purchase |
2024-05-28 8:40 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
170,000 | $20.15 | $3,424,989 | 3,692,697 (Indirect Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 6:16 pm |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner |
50,000 | $23.31 | $1,165,295 | 3,522,697 (Indirect Direct) |
View |
| 2024-04-29 Sale |
2024-04-30 4:30 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,325 | $11.04 | $69,808 | 106,861 (Direct) |
View |
| 2024-04-29 Sale |
2024-04-30 4:27 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
1,104 | $11.04 | $12,185 | 36,862 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:15 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
8,559 | $10.59 | $90,661 | 291,698 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:14 pm |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
2,008 | $10.59 | $21,269 | 90,879 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:14 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
3,253 | $10.59 | $34,455 | 115,290 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 4:28 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
931 | $9.2097 | $8,574 | 24,983 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 4:24 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
2,618 | $9.2097 | $24,111 | 56,507 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-01 Other |
2024-08-05 5:32 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Director 10% Owner |
413,655 | $32.25 | 4,276,352 (Direct) |
View |
| 2024-07-29 Exercise |
2024-07-31 4:40 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
3,874 | $0 | 119,668 (Direct) |
View |
| 2024-07-29 Exercise |
2024-07-31 4:39 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
753 | $0 | 43,161 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:19 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:18 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Leproust Emily M. Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:16 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:15 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Ryan Jason Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:13 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Meister Keith A. Director 10% Owner |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 7:04 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner |
5,828 | $0 | 3,867,148 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:42 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Leproust Emily M. Director |
5,828 | $0 | 8,352 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:41 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director |
5,828 | $0 | 27,664 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:40 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director |
5,828 | $0 | 202,117 (Direct) |
View |
| 2024-06-20 Exercise |
2024-06-24 5:39 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Meister Keith A. Director 10% Owner |
5,828 | $0 | 3,647,868 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:18 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
7,197 | $0 | 116,575 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:17 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
18,750 | $0 | 297,080 (Direct) |
View |
| 2024-06-09 Exercise |
2024-06-11 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,462 | $0 | 57,479 (Direct) |
View |
| 2024-06-09 Exercise |
2024-06-11 4:13 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,546 | $0 | 145,228 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:20 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
717 | $0 | 37,747 (Direct) |
View |
| 2024-05-02 Exercise |
2024-05-03 4:04 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director |
918 | $0 | 22,754 (Direct) |
View |
| 2024-04-29 Exercise |
2024-04-30 4:30 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
15,496 | $0 | 106,861 (Direct) |
View |
| 2024-04-29 Exercise |
2024-04-30 4:27 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
3,013 | $0 | 36,862 (Direct) |
View |
| 2024-03-16 Exercise |
2024-03-19 4:15 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER |
18,750 | $0 | 291,698 (Direct) |
View |
| 2024-03-16 Exercise |
2024-03-19 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Saad Kareem CHIEF TRANSFORMATION OFFICER |
5,114 | $0 | 90,879 (Direct) |
View |
| 2024-03-16 Exercise |
2024-03-19 4:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
7,197 | $0 | 115,290 (Direct) |
View |